Max Robotics — Global Service Robot Directory + US Certification

About

Erika Scoccimarro is a leading clinical researcher in radiation oncology, with a focused expertise in breast cancer treatment and stereotactic radiosurgery. Her major contributions center on advancing preoperative partial breast irradiation (PBI), particularly through the innovative use of robotic radiosurgery to treat early-stage breast cancer. As the lead investigator of the landmark phase II ROCK trial (NCT03520894), Scoccimarro demonstrated that preoperative robotic radiosurgery can precisely target well-defined tumors, potentially improving outcomes and reducing toxicity compared to conventional postoperative radiotherapy. Her work has garnered significant attention, with her most-cited paper accumulating 29 citations and shaping clinical protocols for non-invasive breast cancer management. Beyond this trial, Scoccimarro’s research portfolio explores optimizing radiation delivery techniques, integrating advanced imaging for tumor delineation, and evaluating long-term patient-reported outcomes. Her achievements include presenting at major international oncology conferences and contributing to guidelines that bridge surgical and radiotherapeutic approaches. For students and researchers, Scoccimarro exemplifies how rigorous phase II trial design can translate technological innovation into tangible clinical benefits, offering a model for personalized, less invasive cancer care.